Latest news on Laboratorytalk categorised by supplier
DXS
Address:
48 Grafton Street Manchester
M13 9XX
United Kingdom
Telephone: (United Kingdom) +44 161 606 7201
http://www.dxsgenotyping.com
Our RSS feed for news from DXS
Request to receive our free email newsletter each week
Listing of all 12 news releases from DXS:
Genzyme announces sublicense agreement with DxS
The license permits DxS to commercialise diagnostic and research products that detect mutations in the kinase domain of the EGFR gene
News from DXS (21 February 2008)
Securing Scorpions technology for R+D use
DxS and Epigenomics enter into cross-licensing agreement for the use of Scorpions technology in DNA methylation based testing
News from DXS (15 January 2008)
Kit used to assess tumour mutation status
User application article DxS K-Ras mutation detection kit used to assess tumour mutation status prior to treatment with Amgen's Vectibix
News from DXS (27 September 2007)
Assay detects V600E mutation in the B-RAF oncogene
The DxS B-RAF assay detects V600E, the most common mutation in the B-RAF oncogene, which occurs in many types of cancer including melanoma, colorectal and lung
News from DXS (18 September 2007)
Biotechnology award from BioNow for cancer product
DxS has won a coveted 'Biotechnology Project of the Year' award for its highly sensitive EGFR (epidermal growth factor receptor) mutation test kit
News from DXS (30 November 2006)
Clinical pharmacology collaboration
User application article DxS, a personalised medicine company, will assist the AstraZeneca research fellow at University of Manchester in the development of mutation detection assays using its Scorpions and Arms technologies
News from DXS ( 8 August 2006)
New mutation test kit from DxS
Improving the detection of T790M mutations on the EGFR gene Lung cancer patients using a new mutation test kit from DxS.
News from DXS (26 July 2006)
EGFR mutation could lead to less invasive testing
Superior performance of EGFR mutation test kit creates scope for blood-based prediction of drug response in lung cancer, according to a paper in Clinical Cancer Research
News from DXS (12 July 2006)
Brothers in Arms win licence extension
Technical background article Amplification refractory mutation system technology (Arms) is a well-established and reliable method for the detection of genetic variations and single nucleotide polymorphisms (SNPs)
News from DXS (10 January 2006)
Human IVD extension of probe licence
Probes are highly sensitive, sequence-specific, bi-functional molecules containing a PCR primer covalently linked to a probe
News from DXS ( 6 December 2005)
UK Biobank invests in genetic expertise
User application article Pilot study confirms that collection and transport of volunteer's blood from sites around the UK to the Biobank laboratories in Manchester could be undertaken without any reduction in sample quality
News from DXS (14 September 2005)
Cutting a deal for sequencing probes
Probes are highly sensitive, sequence-specific, bi-functional molecules containing a PCR primer covalently linked to a probe
News from DXS (29 July 2005)
